Skip to main content
. 2023 Sep 21;20(1):34–46. doi: 10.1002/alz.13452

TABLE 1.

Demographic and clinical information for study participants

Females (n = 987) Males (n = 1132)
Age 72.3 ± 7.2 74.2 ± 7.1 a
Education 15.6 ± 2.7 16.4 ± 2.8 a
APOE ϵ4+ 440 (45%) 512 (45%)
Baseline diagnosis
NC 424 (54%) 346 (42%) a
MCI 398 (31%) 579 (40%) a
AD 165 (15%) 207 (18%)
BMI 26.6 ± 5.5 27.2 ± 4.1
Systolic BP 134.3 ± 17.7 134.7 ± 17.2
Diastolic BP 73.9 ± 10.2 75.1 ± 9.6
Hypertension 435 (44%) 574 (51%) a
Diabetes 54 (5%) 111 (10%) a
Stroke 8 (1%) 19 (2%)
Smoking 276 (28%) 436 (39%) a
Alcohol abuse 21 (2%) 61 (6%) a
Hachinski score
0 509 (51.5%) 517 (46%)
1 419 (42.5%) 540 (48%)
2 33 (3.3%) 44 (4%)
3 24 (2%) 25 (2%)
4 2 (< 1%) 6 (< 1%)

Notes: Values are represented as mean ± standard deviation or as the amount of the sample and percentage of sample with that trait.

Abbreviations: AD, Alzheimer's disease; APOE, apolipoprotein E; BMI, body mass index; BP, blood pressure; MCI, mild cognitive impairment; NC, normal controls.

a

Males had statistically (p < 0.05) increased age, higher education, more MCI participants and fewer NCs, and higher rates of hypertension, diabetes, smoking, and alcohol abuse.